Good morning :)

Tickertape - Financial freedom begins here

Wed
Thu
Fri
Mon
Today7:50PM

Market and sectors

See All
NIFTY 50
25,459.350.99%
USD/INR
91.120.06%
Gold
0.00100.00%
NIFTY 100 Largecap
26,150.300.78%
NIFTY 100 Midcap
59,184.950.12%
NIFTY 100 Smallcap
16,997.750.32%
NIFTY Bank
61,094.000.28%
NIFTY IT
30,158.704.41%
NIFTY Pharma
22,690.400.50%
Today's stocks
  • Large Cap
  • switcher
STOCKSPRICECHANGE

1,037.103.32%

watchlist

24,903.002.72%

watchlist

1,735.102.68%

watchlist

6,056.002.34%

watchlist

180.192.11%

watchlist

Mutual funds and ETFs

  • 1Y Return
  • switcher
FUNDSRETURNS
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
native-add
native-add
native-add
native-add
native-add
native-add

Market and sectors

See All
NIFTY 50
25,459.350.99%
USD/INR
91.120.06%
Gold
0.00100.00%
NIFTY 100 Largecap
26,150.300.78%
NIFTY 100 Midcap
59,184.950.12%
NIFTY 100 Smallcap
16,997.750.32%
NIFTY Bank
61,094.000.28%
NIFTY IT
30,158.704.41%
NIFTY Pharma
22,690.400.50%
Today's stocks
  • Large Cap
  • switcher
STOCKSPRICECHANGE

1,037.103.32%

watchlist

24,903.002.72%

watchlist

1,735.102.68%

watchlist

6,056.002.34%

watchlist

180.192.11%

watchlist

Curated screens and deals

Today's news and events
  • Market
  • switcher
Corporate
IIFLIIFL Finance to issue NCDs up to Rs 1,000 cr

IIFL Finance has approved the issuance of up to 1 lakh senior, secured, listed, rated, redeemable Non-Convertible Debentures (NCDs) of face value of Rs 1 lakh each aggregating to up to Rs 1,000 crore on a private placement basis.Powered by Capital Market - Live

5 hours agoCapital Market - Live
Corporate
HCGHealthcare Global Enterprises board approves terms of rights issue

The board of Healthcare Global Enterprises at its meeting held on 24 February 2025 has approved the terms of rights issue: Instrument: Fully paid-up equity shares of face value of Rs 10 each. Total number of Rights Equity Shares and Rights Issue size: 82,94,566 Rights Equity Shares each for an amount aggregating to Rs 424.68 crore (assuming full subscription and payment of call monies). Rights Issue Price: Rs 512 (Rupees Five Hundred and Twelve only) per Rights Equity Share (including a premium of Rs 502 (Rupees Five Hundred and Two only) per Rights Equity Share) Concept of Rights Entitlement: The shareholders holding equity shares of the Company as on the Record date ('eligible equity shareholders') will be entitled to Rights Entitlement ('REs'). REs shall be credited prior to the issue opening date, in the respective demat account of the eligible equity shareholders ('RE Holders') under the ISIN: INE075I20017. The Company has made necessary arrangements with NSDL and CDSL for credit of REs in the respective demat account of the eligible equity shareholders. RE holders can apply for Rights Issue or renounce the REs in full or in part. Record date: 02 March 2026 Issue opening date: 11 March 2026 Issue closing date: 25 March 2026 Date of listing of rights issue: 01 April 2026 Rights Entitlement Ratio: The Rights Equity Shares are being offered on a rights basis to Eligible Equity Shareholders in the ratio of 1 (One) Rights Equity Shares for every 17 (Seventeen) fully paid-up Equity Shares held on the Record Date. Powered by Capital Market - Live

5 hours agoCapital Market - Live
Corporate
5PAISA5paisa Capital approves rights issue of Rs 475 cr

The board of 5paisa Capital at its meeting held on 24 February 2026 has approved raising of funds not exceeding Rs 475 crore by way of rights issue of equity shares. Powered by Capital Market - Live

5 hours agoCapital Market - Live
See All

Ready-made PortfoliosInvestment Products

bysmallcase logosmallcase

Mutual funds and ETFs

  • 1Y Return
  • switcher
FUNDSRETURNS
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist
Equity
Growth
watchlist

Money
Matters

Everything you need to redefine your investing experience
  • Assets tracked worth
    60,500 Cr
  • Loved by
    60 L+ investors
  • Downloads
    6.2M+
  • Rated on Google Play
    4.2